Shilling V, Bailey S, Logan S, Morris C. Child: Care Health and Development. Article first published online: 17 Dec 2014. doi: 10.1111/cch.12223.

Francis A, Fallowfield L, Rea D.  The LORIS Trial: Addressing Overtreatment of Ductal Carcinoma In Situ Clinical Oncology 2015, 27(1):6-8 doi: 10.1016/j.clon.2014.09.015. E-published in 2014

Fallowfield L, Jenkins V. Psychosocial/Survivorship Issues in Breast Cancer: Are We Doing Better? JNCI Journal of the National Cancer Institute 2014, 107(11), doi:10.1093/jnci/dju335

Palmieri C, Cleator S, Kilburn LS, Kim SB, Ahn SH, Beresford M, Gong G, Fallowfield L, Cheang M, Morden J, Page K, Guttery DS, Rghebi B, Primrose L, Shaw JA, Thompson AM, Bliss JM, Coombes RC. NEOCENT: a randomised feasibility and translational study comparing neoadjuvant endocrine therapy with chemotherapy in ER-rich postmenopausal primary breast cancer. Breast Cancer Research and Treatment 148(3):581-590. doi:10.1007/s10549-014-3183-4

Fallowfield L, Guarneri V, Ozturk MA, May S, Jenkins V. Blurring of boundaries in the doctor-patient relationship. The Lancet Oncology, 15(13);1423-1424 doi:10.1016/S1470-2045(14)71122-2

Cherny NI, de Vries EGE, Emanuel L, Fallowfield L, Francis PA, Gabison A, Piccart MJ, Sidransky D, Soussan-Gutman L, Tziraki C. Words Matter: Distinguishing “Personalized Medicine” and “Biologically Personalized Therapeutics” Journal of the National Cancer Institute 106(12): dju321 doi:10.1093/jnci/dju321

Hopkins TG, Stavraka C, Gabra H, Fallowfield L, Hood C, Blagden S. Sexual activity and functioning in ovarian cancer survivors: an internet-based evaluation. Climacteric 2015 Feb;18(1):94-8 epublished 2014

Cardoso F, Costa A, Norton L, Senkus E, Aapro M, Andre F, Barrios CH, Bergh J, Biganzoli L, Blackwell KL, Cardoso MJ, Cufer T, El Saghir N, Fallowfield L, Fenech D, Francis P, Gelmon K, Giordano SH, Gligorov J, Goldhirsch A, Harbeck N, Houssami N, Hudis C, Kaufman B, Krop I, Kyriakides S, Lin UN, Mayer M, Merjaver SD, Nordstrom EB, Pagani O, Partridge A, Penault-Llorca F, Piccart MJ, Rugo H, Sledge G, Thomssen C, van't Veer L, Vorobiof D, Vrieling C, West N, Xu B, Winer E. ESO-ESMO 2nd international consensus guidelines for advanced breast cancer (ABC2). Annals of Oncology, 25(10);1871-1888 published simultaneously in The Breast, 23(5);489-502

Gligorov J, Müller V, Curigliano G, Knoop A, Verma S, Jenkins V, Scotto N, Osborne S, Fallowfield L on behalf of the PrefHer Study Group. Patients' preferences for subcutaneous trastuzumab versus conventional intravenous infusion for the adjuvant treatment of HER2-positive early breast cancer: final analysis of 488 patients in the international, randomized, two-cohort PrefHer study. Annals of Oncology 25:1979-1987

Fallowfield L, Matthews L, Francis A, Jenkins V, Rea D. Low grade Ductal Carcinoma in situ (DCIS): How best to describe it?. The Breast, 23(5); 693-696

Stoner KL, Harder H, Fallowfield LJ, Jenkins VA. Intravenous versus Subcutaneous Drug Administration. Which do Patients Prefer? A Systematic Review. The Patient - Patient-Centred Outcomes Research 2015, 8(2):145-153. E-Published 12 July 2014

El Saghir NS, Keating NL, Carlson RW, Khoury KE, Fallowfield L. Tumor boards: optimizing the structure and improving efficiency of multidisciplinary management of patients with cancer worldwide. American Society of Clinical Oncology Education Book 2014;34:e461-6

Treasure T, Brew-Graves C, Fallowfield L, Farewell V, Golesworthy T, Leonard P, Monson K, Russell C. The need to determine whether lung metastasectomy improves survival in advanced colorectal cancer.  British Medical Journal Letters BMJ 2014;348:g4085

Barrett J, Jenkins V, Farewell , Menon U, Jacobs I, Kilkerr J, Ryan A, Langridge C, Fallowfield L for and on behalf of UKCTOCS trialists. Psychological morbidity associated with ovarian cancer screening: results from more than 23 000 women in the randomised trial of ovarian cancer screening (UKCTOCS)BJOG An International Journal of Obstetrics & Gynaecology. 2014, 121(9):1071–1079

Treasure T, Monson K, Fiorentino F, Russell C. The CEA Second-Look Trial: a randomised controlled trial of carcinoembryonic antigen prompted reoperation for recurrent colorectal cancer.  British Medical Journal Open 2014:e004385. doi:10.1136/bmjopen-2013-004385

Treasure T, Monson K, Fiorentino F, Russell C. Operating to remove recurrent colorectal cancer: have we got it right?  British Medical Journal Open 2014:348:g2085. doi:10.1136/bmj.g2085

Fallowfield L, Langridge C, Jenkins V. Communication skills training for breast cancer teams talking about trials.  The Breast 23(2): 193-197, 2014 http://dx.doi.org/10.1016/j.breast.2013.11.009

^ Top